FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Erika Adkins Scholl

Research Profile

Chemicals & Drugs

Anatomy

Co-author Network

Publications

TOP 3
Brad R Green; Karen L White; Daniel R McDougle; Liuyin Zhang; Brian Klein; Erika Adkins Scholl; Timothy H Pruess; H White; Grzegorz Bulaj
Introduction of lipidization-cationization motifs affords systemically bioavailable neuropeptide Y and neurotensin analogs with anticonvulsant activities.
Charles R Robertson; Erika Adkins Scholl; Timothy H Pruess; Brad R Green; H White; Grzegorz Bulaj
Engineering galanin analogues that discriminate between GalR1 and GalR2 receptor subtypes and exhibit anticonvulsant activity following systemic delivery.
H White; Erika Adkins Scholl; Brian D Klein; Sean P Flynn; Timothy H Pruess; Brad R Green; Liuyin Zhang; Grzegorz Bulaj
Developing novel antiepileptic drugs: characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Erika Adkins Scholl (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Brad R Green; Karen L White; Daniel R McDougle; Liuyin Zhang; Brian Klein; Erika Adkins Scholl; Timothy H Pruess; H White; Grzegorz Bulaj
Introduction of lipidization-cationization motifs affords systemically bioavailable neuropeptide Y and neurotensin analogs with anticonvulsant activities.
Journal of peptide science : an official publication of the European Peptide Society 2010;16(9):486-95.
2010: Charles R Robertson; Erika Adkins Scholl; Timothy H Pruess; Brad R Green; H White; Grzegorz Bulaj
Engineering galanin analogues that discriminate between GalR1 and GalR2 receptor subtypes and exhibit anticonvulsant activity following systemic delivery.
Journal of medicinal chemistry 2010;53(4):1871-5.
2009: H White; Erika Adkins Scholl; Brian D Klein; Sean P Flynn; Timothy H Pruess; Brad R Green; Liuyin Zhang; Grzegorz Bulaj
Developing novel antiepileptic drugs: characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2009;6(2):372-80.
2008: Grzegorz Bulaj; Brad R Green; Hee-Kyoung Lee; Charles R Robertson; Karen White; Liuyin Zhang; Marianna Sochanska; Sean P Flynn; Erika Adkins Scholl; Timothy H Pruess; Misty Smith; H Steve White
Design, synthesis, and characterization of high-affinity, systemically-active galanin analogues with potent anticonvulsant activities.
Journal of medicinal chemistry 2008;51(24):8038-47.
2008: Attila Kumánovics; Opal S. Chen; Liangtao Li; Dustin Bagley; Erika Adkins Scholl; Huilan Lin; Nin N Dingra; Caryn Outten; Greg Keller; Dennis R Winge; Diane McVey Ward; Jerry Kaplan
Identification of FRA1 and FRA2 as genes involved in regulating the yeast iron regulon in response to decreased mitochondrial iron-sulfur cluster synthesis.
The Journal of biological chemistry 2008;283(16):10276-86.
2007: Erika Adkins Scholl; Devadoss J Samuvel; Jacob U Fog; Jacob Eriksen; Lankupalle D Jayanthi; Christian Vaegter; Sammanda Ramamoorthy; Ulrik Gether
Membrane mobility and microdomain association of the dopamine transporter studied with fluorescence correlation spectroscopy and fluorescence recovery after photobleaching.
Biochemistry 2007;46(37):10484-97.
2006: Robert J Crisp; Erika Adkins Scholl; Emily Kimmel; Jerry Kaplan
Recruitment of Tup1p and Cti6p regulates heme-deficient expression of Aft1p target genes.
The EMBO journal 2006;25(3):512-21.
2006: Keith Henry; Julie R Field; Erika Adkins Scholl; M Laura Parnas; Roxanne A Vaughan; Mu-Fa Zou; Amy Hauck Newman; Randy D Blakely
Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants.
The Journal of biological chemistry 2006;281(4):2012-23.
2005: Joo Hwan Cha; Mu-Fa Zou; Erika Adkins Scholl; Søren G F Rasmussen; Claus Loland; Bernhard Schoenenberger; Ulrik Gether; Amy Hauck Newman
Rhodamine-labeled 2beta-carbomethoxy-3beta-(3,4-dichlorophenyl)tropane analogues as high-affinity fluorescent probes for the dopamine transporter.
Journal of medicinal chemistry 2005;48(24):7513-6.
2003: Søren G F Rasmussen; Erika Adkins Scholl; Frank carroll; Martin J Maresch; Ulrik Gether
Structural and functional probing of the biogenic amine transporters by fluorescence spectroscopy.
European journal of pharmacology 2003;479(1-3):13-22.
2003: Keith Henry; Erika Adkins Scholl; Qiao Han; Randy D Blakely
Serotonin and cocaine-sensitive inactivation of human serotonin transporters by methanethiosulfonates targeted to transmembrane domain I.
The Journal of biological chemistry 2003;278(39):37052-63.
2002: Sandra J Rosenthal; Ian Tomlinson; Erika Adkins Scholl; Sally Schroeter; Scott Adams; Laura Swafford; James McBride; Yongqiang Wang; Louis J DeFelice; Randy D Blakely
Targeting cell surface receptors with ligand-conjugated nanocrystals.
Journal of the American Chemical Society 2002;124(17):4586-94.
2001: Erika Adkins Scholl; Eric L Barker; Randy D Blakely
Interactions of tryptamine derivatives with serotonin transporter species variants implicate transmembrane domain I in substrate recognition.
Molecular pharmacology 2001;59(3):514-23.
1998: Eric L Barker; M A Perlman; Erika Adkins Scholl; W J Houlihan; Zdenek Pristupa; Hyman B Niznik; Randy D Blakely
High affinity recognition of serotonin transporter antagonists defined by species-scanning mutagenesis. An aromatic residue in transmembrane domain I dictates species-selective recognition of citalopram and mazindol.
The Journal of biological chemistry 1998;273(31):19459-68.